Life Sciences 2013-05-01

Nefiracetam attenuates post-ischemic nonconvulsive seizures in rats and protects neuronal cell death induced by veratridine and glutamate.

Xi-ChunMay Lu, JitendraR Dave, Zhiyong Chen, Ying Cao, Zhilin Liao, FrankC Tortella

Index: Life Sci. 92(22) , 1055-63, (2013)

Full Text: HTML

Abstract

Stroke patients are at a high risk of developing post-ischemic seizures and cognitive impairment. Nefiracetam (NEF), a pyrrolidone derivative, has been shown to possess both anti-epileptic and cognitive-enhancing properties. In this study the anti-seizure effects of NEF were evaluated in a rat model of post-ischemic nonconvulsive seizures (NCSs). Its potential mechanisms were investigated in neuronal cell culture assays of neurotoxicity associated with ischemic brain injury and epileptogenesis.

Related Compounds

  • Nefiracetam
  • Veratridine

Related Articles:

Investigation on urinary proteins and renal mRNA expression in canine renal papillary necrosis induced by nefiracetam.

2005-09-01

[Arch. Toxicol. 79(9) , 500-7, (2005)]

Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.

2009-05-05

[Neuroscience 160(2) , 484-91, (2009)]

Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.

2005-06-01

[Epilepsia 46(6) , 811-8, (2005)]

Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam.

2004-10-01

[Ann. N. Y. Acad. Sci. 1025 , 389-97, (2004)]

Nefiracetam, a novel cognition-enhancing agent. An introductory overview.

1994-02-01

[Arzneimittelforschung 44(2A) , 193-4, (1994)]

More Articles...